Ключевые слова
Аннотация
Ковид-19 пандемияси дунё бўйлаб соғлиқни сақлаш тизимини жиддий синовдан ўтказди. Вируснинг инсон иммун тизимига бўлган салбий таъсири кўплаб иллатларнинг ривожланишини ёки кучайишини олиб келди. Шу билан бирга, ковид-19нинг иммун тизимини заифлаштириши, узоқ муддатли асоратлар ва касалликлар, хусусан, инфекцион касалликлар, биринчи навбатда туберкулёз спондилитининг тараққиётига сабаб бўлди. Туберкулёз спондилити, умуртқа поғонасининг инфекцион яллиғланиши, одатда иммун тизими заифлашган одамларда ривожланади. Ковид-19 пандемияси туфайли одамларнинг иммун тизими олиб келган ўзгаришлар, шунингдек, туберкулёзнинг клиник кўринишларининг қайта кучайишига олиб келиши мумкин.
Ковид-19 ва туберкулёз спондилитига ўхшаш иллатлар ўртасидаги ўзаро алоқа ва таъсирларни тадқиқ этиш, уларнинг барвақт аниқланиши ва самарали даволаш усулларини ишлаб чиқиш аҳамиятлидир. Бу мақолада ковид-19нинг туберкулёз спондилитининг ривожланишидаги ролини ўрганиш, ушбу касалликни даволашдаги янги ёндашувлар ва клиник хатти-ҳаракатлар ҳамда профилактика стратегияларига эътибор қаратамиз.
Библиографические ссылки
World Health Organization (WHO). (2020). Coronavirus disease (COVID-19) pandemic. https://www.who.int
Berbari, E. F., & Schemitsch, E. H. (2020). Spinal tuberculosis: A review of the literature. The Journal of Bone and Joint Surgery, 102(9), 753-761.
Agarwal, A., et al. (2021). COVID-19 and Tuberculosis: A Review of Co-infection Studies. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 24, 100213.
Mohan, A., et al. (2020). Impact of COVID-19 on tuberculosis diagnosis and management: A review. Journal of Clinical and Diagnostic Research, 14(7), LE01-LE05.
Singh, P., & Sharma, S. (2020). COVID-19 and its impact on tuberculosis: A review. Indian Journal of Tuberculosis, 67(2), 187-191.
Khanna, A., et al. (2021). Tuberculosis in the COVID-19 Era: The Overlooked Pandemic. The Lancet Infectious Diseases, 21(9), 1222-1228.
Murray, C. J., et al. (2020). Global tuberculosis report 2020. World Health Organization. https://www.who.int/tb/publications/global_report/en/
Kaufman, H. W., & Alpert, T. (2021). Spinal tuberculosis in the COVID-19 era: A review of cases and challenges. The Spine Journal, 21(5), 835-839.
Yang, X., et al. (2020). Tuberculosis and COVID-19: A dual epidemic in the context of a global health crisis. Journal of Infection, 81(5), e89-e92.
Vasudevan, R., et al. (2021). Immune Response in COVID-19 and Its Effect on Tuberculosis: A Review. Journal of Infection and Public Health, 14(5), 592-598.
Siddiqui, N., et al. (2021). The Impact of COVID-19 on Tuberculosis: A Review of Current Evidence. Tuberculosis Research and Treatment, 2021, 2636451.
Chandran, A., et al. (2020). Tuberculosis Spinal Involvement in the COVID-19 Era. Asian Spine Journal, 14(5), 712-719.
Tariq, A., et al. (2021). COVID-19 and tuberculosis co-infection: Diagnosis, treatment challenges, and future perspectives. Frontiers in Public Health, 9, 638.
Kumar, M., et al. (2020). The double burden: COVID-19 and tuberculosis co-infection and its challenges. Tuberculosis, 122, 101907.
Hussain, S. S., & Haseeb, M. (2021). Tuberculosis spindylitis in the COVID-19 era: A review of the global impact and response strategies. Journal of Infection and Public Health, 14(7), 906-913.